Clinical trial
Hepcidin in the Pathogenesis of Anemia in Patients With Chronic Heart Failure
NCT00437866 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepcidin in the Pathogenesis of Anemia in Patients With Chronic Heart Failure
- Lead sponsor
- Medical University of Vienna
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- July 31, 2010
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, chronic heart failure